相关实验视频
Updated: Jul 19, 2025
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
141
异形性肺纤维化:当前的诊断和治疗
Alexandre Franco Amaral1, Philippe de Figueiredo Braga Colares1, Ronaldo Adib Kairalla1
1. Divisão de Pneumologia, Instituto do Coração - InCor - Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo (SP) Brasil.
概括
异形性肺纤维化 (IPF) 管理已取得显著进展. 这次审查涵盖了IPF.
科学领域:
- 肺病学和呼吸系统医学
- 纤维化间歇性肺病 纤维化间歇性肺病
背景情况:
- 异形性肺纤维化 (IPF) 是一种进展性,不可逆转的肺部疾病,病因不明.
- 最近的诊断和治疗方面的进步重新塑造了IPF患者的护理.
- IPF管理策略会影响其他纤维化间歇性肺病.
研究的目的:
- 提供IPF临床表现,病理生理学和诊断标准的全面概述.
- 审查临床试验之外的抗纤维菌疗法的现有证据.
- 讨论伴随性疾病和非药物治疗在IPF管理中的影响.
主要方法:
- 关于IPF诊断和治疗近期进展的文献综述.
- 在现实环境中分析抗纤维素使用的证据.
- 探索治疗策略,包括并发症和非药物干预.
主要成果:
- IPF的诊断和治疗已经进化,改善了患者的治疗结果.
- 抗纤维素药物在临床试验之外也显示出有效性.
- 在IPF管理中,并发症和非药物治疗方法至关重要.
结论:
- 对IPF的理解和管理已经取得了实质性的进展.
- 有证据支持扩大抗纤维素药物和综合护理模型的使用.
- 需要进一步的研究来优化全面的IPF治疗策略.
相关概念视频
01:24Cystic Fibrosis: Management
194
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
194
01:20COPD: Pathogenesis and Clinical Features
344
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
344
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:28Pneumonia IV: Management
359
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
359
01:28Pulmonary Tuberculosis V
201
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
201
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K